Evaluating the Safety and Immune Response to Different Combinations of the DNA-HIV-PT123 and AIDSVAX® B/E Vaccines in Healthy, HIV-Uninfected Adults
Clinical trial NCT02207920 · COMPLETED
Trial details
- NCT number
- NCT02207920
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2015-12-01
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.